You just read:

Theravance Biopharma Reports Encouraging Data from First Cohort of Patients in Phase 1b Clinical Trial of TD-1473 in Ulcerative Colitis

News provided by

Theravance Biopharma, Inc.

Aug 08, 2017, 16:05 ET